Krishna Institute of Medical Sciences Future Growth
Future criteria checks 3/6
Krishna Institute of Medical Sciences is forecast to grow earnings and revenue by 17.9% and 15.5% per annum respectively. EPS is expected to grow by 18.5% per annum. Return on equity is forecast to be 18% in 3 years.
Key information
17.9%
Earnings growth rate
18.5%
EPS growth rate
| Healthcare earnings growth | 25.7% |
| Revenue growth rate | 15.5% |
| Future return on equity | 18.0% |
| Analyst coverage | Good |
| Last updated | 19 Jun 2024 |
Recent future growth updates
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Recent updates
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 44,031 | 5,686 | 3,914 | 8,525 | 4 |
| 3/31/2026 | 35,562 | 4,431 | 2,603 | 7,424 | 11 |
| 3/31/2025 | 29,527 | 3,727 | -1,136 | 6,202 | 11 |
| 3/31/2024 | 24,981 | 3,101 | -1,262 | 5,211 | N/A |
| 12/31/2023 | 24,403 | 3,379 | N/A | N/A | N/A |
| 9/30/2023 | 23,966 | 3,421 | -2,263 | 4,621 | N/A |
| 6/30/2023 | 23,082 | 3,472 | N/A | N/A | N/A |
| 3/31/2023 | 21,977 | 3,363 | -1,424 | 4,321 | N/A |
| 12/31/2022 | 19,941 | 3,237 | N/A | N/A | N/A |
| 9/30/2022 | 18,255 | 3,289 | 741 | 3,693 | N/A |
| 6/30/2022 | 16,732 | 3,135 | N/A | N/A | N/A |
| 3/31/2022 | 16,508 | 3,327 | 1,537 | 3,240 | N/A |
| 12/31/2021 | 16,370 | 3,098 | N/A | N/A | N/A |
| 9/30/2021 | 16,041 | 2,774 | 2,318 | 3,488 | N/A |
| 6/30/2021 | 16,020 | 2,792 | N/A | N/A | N/A |
| 3/31/2021 | 13,299 | 2,012 | 2,615 | 3,560 | N/A |
| 12/31/2020 | 12,412 | 1,721 | 3,180 | 3,774 | N/A |
| 3/31/2020 | 11,227 | 1,192 | 1,495 | 2,015 | N/A |
| 3/31/2019 | 9,204 | -477 | 566 | 1,339 | N/A |
| 3/31/2018 | 6,652 | -474 | 473 | 1,058 | N/A |
| 3/31/2017 | 5,689 | 326 | N/A | 815 | N/A |
| 3/31/2016 | 5,145 | 266 | N/A | 955 | N/A |
| 3/31/2015 | 4,222 | 56 | N/A | 639 | N/A |
| 3/31/2014 | 3,569 | 69 | N/A | 778 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KIMS's forecast earnings growth (17.9% per year) is above the savings rate (6.7%).
Earnings vs Market: KIMS's earnings (17.9% per year) are forecast to grow faster than the Indian market (15.9% per year).
High Growth Earnings: KIMS's earnings are forecast to grow, but not significantly.
Revenue vs Market: KIMS's revenue (15.5% per year) is forecast to grow faster than the Indian market (9.6% per year).
High Growth Revenue: KIMS's revenue (15.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KIMS's Return on Equity is forecast to be low in 3 years time (18%).